Introduction
Focal epilepsies account for about two-thirds of all adult patients with epilepsy, and temporal lobe epilepsy (TLE) is the most common type of focal epilepsy 1, 2 . Mesial temporal sclerosis (MTS) is the most common pathological substrate of TLE 3 and about 70% of patients with drug-resistant TLE show signs of MTS on their MRI 4 . Temporal lobe epilepsy is the most common type of drug-resistant epilepsy referred for epilepsy surgery; it often responds favorably to surgery 5, 6 . The potential efficacy of resective surgery in patients with TLE uncontrolled by anti-epileptic drugs is undisputed. However, there are still uncertainties about which patients will benefit most 7 . Various centers use different methodologies in their research. In addition, they often report the combined results from patients with TLE due to MTS and other etiologies as well as nonlesional patients. Such discrepancies may explain the wide variation in seizure free rates after surgery for TLE and they may also obfuscate factors that influence postoperative seizure outcome in these patients 6, 7 .
In order to obtain a clearer picture of the possible influence of risk factors on postoperative seizure outcome for patients with drug-resistant MTS-TLE, we conducted a retrospective study of a large surgical cohort. We examined seizure outcome during long-term postsurgical follow-up in patients with magnetic resonance imaging (MRI)-proven MTS-TLE who had undergone epilepsy surgery for drug-resistant seizures. This may shed light on the significance of distinguishing specific types and etiologies of TLE when predicting outcome after surgery.
Material and methods
In this retrospective study, we examined data from all patients with a clinical diagnosis of drug-resistant MTS-TLE who underwent epilepsy surgery at Jefferson Comprehensive Epilepsy
Center between 1986 and 2014 and had a minimum of 1-year postoperative follow-up. Historical data was obtained by board certified neurologists. The diagnosis of TLE was made by the epileptologists working at this institution and based on clinical grounds (history and semiology) and electroencephalographic (EEG) findings, in order to retain the diagnosis of mesial TLE.
There was no age limit to enter the study. All patients underwent a comprehensive presurgical evaluation including a brain MRI, prolonged video-EEG monitoring, neuropsychological evaluation, etc. Magnetic resonance imaging studies were analyzed by neuroradiologists, neurologists, and neurosurgeons with expertise in epilepsy in order to ascertain the diagnosis of MTS. A positive MRI scan for evidence of MTS was required for inclusion in the study. We classified patients as having MTS if they had clear signs of mesial temporal atrophy and/or sclerosis in their brain MRI. Pathology specimens were reviewed by pathologists, but most results were not sufficient to make a precise pathological classification. Patients with dual pathology (in their MRI) and also patients with incomplete data with regard to pre-and postoperative seizure information (i.e., type and frequency) were excluded from this study.
All patients included in the analysis had an anterior temporal lobectomy (ATL).
Resections have evolved over the years, but there has been no difference in treatment strategy.
Early on, we performed lateral resections in the dominant hemisphere 4 cm from the pole; more recently these resections were performed 2-3 cm from the pole. In the nondominant hemisphere, early on we performed lateral resections 5 cm from the pole; more recently 3-4 cm from the pole.
In mesial resections there was no difference in resection size between dominant and 5 nondominant foci. The patients were followed for at least one year and up to five years after surgery (for many patients the data were missing beyond five years of follow-up In a subanalysis, we studied patients who were seizure free and aura free for one year or 
Discussion
Drug-resistant temporal lobe epilepsy is a relatively common type of epilepsy that often responds favorably to surgery. In our study, about half of the patients had sustained seizure freedom during a long-term postsurgical follow-up, which is concordant with most previous studies 6, 7, 10, 11 . This study aimed to resolve ambiguities regarding the prognostic value of historical risk factors in drug-resistant TLE after surgery in patients with MTS. We found that a history of recent preoperative tonic-clonic seizures was associated with postoperative seizure recurrence.
History of febrile seizures in childhood
A history of febrile seizure in the past did not predict the postoperative outcome in patients with drug-resistant MTS-TLE. A previous meta-analysis of predictors of temporal lobectomy outcome in a heterogeneous population of TLE patients found febrile seizures to be a strong prognostic indicator of seizure remission (odds ratio 0.48; 95% confidence interval 0.27-0.83) 7 .
However, other studies that only included patients with MTS found that a history of febrile seizure in childhood did not predict the seizure outcome after surgery 12, 13 ; our study findings are concordant with these studies. Febrile seizures are strongly associated with MTS, which itself is associated with a favorable prognosis. However, as an independent predictor, febrile seizure only predicts outcome when MTS is one of many underlying pathologies in patients with diverse etiologies for their epilepsy. It loses its predictive value when the subgroup of patients with MTS is examined 13 . Febrile seizures are clearly related to MTS at times 14 . MRI findings of a markedly hyperintense hippocampus in children with febrile status epilepticus was highly 10 associated with later development of mesial temporal sclerosis 14, 15 . It appears that it is critical to distinguish among different types and etiologies of TLE when predicting outcome after surgery.
History of tonic-clonic seizures
In our study, the only factor predictive of seizure outcome after surgery in patients with drug-resistant MTS-TLE was the occurrence of tonic-clonic seizures, if there were any in the year preceding surgery. When MRI or pathology clearly shows MTS, then preoperative tonicclonic seizures reduce the chance of postoperative seizure freedom 12 . Another study with a more heterogeneous population of 280 patients who underwent anterior temporal lobectomy also associated a history of secondary generalized tonic-clonic seizure(s) with a lower probability of becoming seizure free (odds ratio 0.47, 95% CI 0.25-0.90; p = 0.02) 16 . Another study of 339 patients followed for more than 2 years found that absence of generalized tonic-clonic seizures and presence of hippocampal atrophy on MRI were significantly associated with remission in patients with medial temporal resection 17 . Recent tonic-clonic seizures in a patient with MTS may reflect more widespread epileptogenicity extending beyond the borders of mesial temporal structures. Evidence obtained with fMRI suggests significant, more widespread derangements in brain function and connectivity in TLE patients with tonic-clonic seizures (compared with those without this seizure type) 18 .
Duration of epilepsy before surgery
Duration of epilepsy before surgery is determined by age at the onset of epilepsy and age at surgery. In our study, duration of epilepsy did not predict seizure outcome after epilepsy surgery in patients with drug-resistant MTS-TLE. Another study of 116 consecutive patients who had temporal lobe surgery for drug-resistant epilepsy and MTS reported similar observations to ours 12 . In contrast, another retrospective study which included 434 consecutive adult patients who underwent TLE surgery found that longer epilepsy duration correlated with poor outcome 9 .
These authors investigated a heterogeneous group of patients including those with MTS and others with tumors or focal cortical dysplasia. As in other variables, better definition of the location within the temporal lobe of the epileptogenic zone may provide better insights.
Intelligence quotient (IQ)
In our study, IQ did not predict postoperative seizure outcome in patients with MTS-TLE. In one previous study, the authors examined the relationship between baseline IQ scores and seizure outcome in 1,034 temporal lobectomy cases from eight epilepsy surgery centers 19 .
Those patients who continued to have seizures following surgery had statistically lower preoperative IQ scores than those who were seizure free (p < 0.009), but only by 2.3 points.
There was considerable overlap between the two groups. However, relative risk analyses revealed no significant increase in risk of surgical failure among patients with low IQ scores who had no structural lesions other than mesial temporal sclerosis 19 . This is consistent with our findings. However, another study that included all resective epilepsy surgeries found a significant relationship between IQ and seizure freedom, with a higher IQ associated with a better outcome 20 . Intelligence quotient may be relevant in epilepsy surgery when etiology is not
considered, but appears to be of no importance in the subset of patients with MTS-TLE.
Seizure frequency
In our study, frequency of preoperative habitual seizures (i.e., either complex partial or generalized tonic-clonic seizures) was not associated with postoperative seizure outcome in patients with MTS-TLE. The data with regard to the role of seizure frequency is inconsistent in the literature. In a previous study of 79 patients with TLE (all etiologies) 8 , those with more than 20 seizures per month were significantly less likely to be seizure free after temporal lobectomy than the rest of patients (p = 0.009). However, another study found that in patients who had anterior temporal lobectomy, preoperative seizure frequency was not associated with postoperative seizure frequency, while in non-ATL operations, preoperative seizure frequency of ≥ 20 seizures per month was associated with frequent postoperative seizures (p = 0.03) 21 . Our data suggests that the frequency of preoperative habitual seizures does not affect surgery outcome in patients with drug-resistant MTS-TLE.
Status epilepticus
In our study, a history of status epilepticus in the past did not predict postoperative outcome in patients with MTS-TLE. This is similar to a previous study of 116 consecutive patients who had temporal lobe surgery for drug-resistant epilepsy and MTS 12 , and contrasts with the findings of another previous study of 118 patients with MTS 13 . A large multicenter study would help assess this issue.
Gender
In our study, gender did not predict postoperative outcome in patients with MTS-TLE. One previous study of 252 patients, who underwent surgical treatment for mesial temporal sclerosis,
showed that male sex was associated with a reduced risk of seizure recurrence (odds ratio, 0.5;
13
95% confidence interval, 0.3-0.8) 22 . However, the same authors in a more recent paper including a larger sample size (368 patients) concluded that gender is not a predictor of long-term outcome following surgery for temporal lobe epilepsy 23 . Other studies 13 have shown similar results to ours.
Race
Race was not a predictor of surgery outcome in patients with drug-resistant MTS-TLE, in our study. The vast majority of previous studies 23 have the same observation. However, one previous study showed a trend for higher rates of seizure recurrence in African-Americans compared with white patients 24 . That study was limited by the small sample size (i.e., 64 patients). In general, epidemiologically race does not seem to affect postoperative seizure outcome in patients with drug-resistant MTS-TLE.
Family history of epilepsy
A family history of epilepsy did not predict postoperative outcome in patients with MTS-TLE, in our study. Similar results were reported in a previous study of 118 patients with MTS 13 .
However, another retrospective study of 434 consecutive patients, who underwent TLE surgery, found a family history of epilepsy to be a predictor of remission 9 . In the latter study, the authors investigated a heterogeneous group of patients including those with MTS, tumors or focal cortical dysplasia. As said before, better definition of the location of the epileptogenic zone may provide better insights.
Conclusions
It is well known that there are several subgroups in TLE (e.g., MTS, TLE plus, pseudo-TLE, etc.) 25, 26 . This research provides further support that differentiating TLE subtypes may ultimately lead to a better understanding of the pathophysiology of the temporal lobe epilepsies.
The potential efficacy of resective surgery in patients with TLE uncontrolled by anti-epileptic drugs is undisputed [27] [28] [29] . However, it is critical to distinguish among different types and etiologies of TLE when predicting seizure outcome after surgery.
Our study places historical risk factors into the equation; however, they are not the only predictors of postoperative seizure outcome. It is essential that all factors (e.g., EEG, other imaging studies, neuropsychological profile, surgery techniques and volume of resection, etc.)
are taken into account. In order to improve algorithms for predicting postoperative seizure outcome in patients with drug-resistant epilepsy, our findings should be combined with those from other studies.
Study limitations
This was a retrospective study and patient data came from a single institution. Imaging techniques have changed with equipment modernization and the general ability to detect abnormalities on MRI scans has improved. Other non-historical factors (e.g., resection size) are not taken into account in this study. Additionally, resections have evolved somewhat over the years, but there has been no difference in treatment strategy. Finally, pathology specimens were reviewed by pathologists, but most results were not sufficient to provide a precise pathological classification.
